杨氏透穴疗法治疗气滞血瘀证颈源性头痛临床研究  

Clinical Study on Yang's Point Penetration Therapy for Cervicogenic Headache with Qi Stagnation and Blood Stasis Syndrome

作　　者：王爱君 金瑛 谢蔚 付桃芳 WANG Aijun;JIN Ying;XIE Wei;FU Taofang(Acupuncture and moxibustion Department,Quzhou Hospital of Traditional Chinese Medicine,Quzhou Zhejiang 324000,China)

机构地区：[1]衢州市中医医院针灸科,浙江衢州324000

出　　处：《新中医》2025年第6期81-85,共5页New Chinese Medicine

基　　金：衢州市科技计划项目(2021081)。

摘　　要：目的:观察杨氏透穴疗法治疗气滞血瘀证颈源性头痛的临床疗效。方法:选择2022年9月—2023年9月衢州市中医医院收治的104例颈源性头痛患者,按照随机数字表法分为对照组、试验组各52例。其中对照组有3例被剔除、1例失访,最终纳入48例;试验组有2例被剔除、1例主动退出,最终纳入49例。对照组口服塞来昔布胶囊,试验组在对照组基础上给予杨氏透穴疗法。治疗4周后,观察2组临床疗效、疼痛情况[视觉模拟评分法(VAS)评分、每天头痛持续时间]、颈椎活动功能评分、中医证候评分、睡眠质量[匹兹堡睡眠质量指数量表(PSQI)]、生活质量[SF-36生活质量调查表(SF-36)]和安全性。结果:试验组总有效率为93.88%(46/49),对照组为79.17%(38/48),2组比较,差异有统计学意义(P<0.05)。治疗后,2组疼痛VAS评分、每天头痛持续时间较均治疗前减少(P<0.05),且试验组疼痛VAS评分、每天头痛持续时间均少于对照组(P<0.05)。治疗后,2组颈部活动功能评分、中医证候评分、PSQI评分均较治疗前降低(P<0.05),且试验组3项评分均低于对照组(P<0.05)。治疗后,2组SF-36评分较治疗前升高(P<0.05),且试验组SF-36评分高于对照组(P<0.05)。治疗期间,2组患者均未出现严重不良事件。结论:杨氏透穴疗法治疗气滞血瘀证颈源性头痛效果良好,可减轻头痛程度和颈椎活动度,改善患者生活质量和睡眠质量。Objective:To observe the clinical effect of Yang's point penetration therapy on cervicogenic headache with qi stagnation and blood stasis syndrome.Methods:A total of 104 patients with cervicogenic headache admitted to Quzhou Hospital of Traditional Chinese Medicine from September 2022 to September 2023 were randomly divided into the control group and the trial group,with 52 patients in each group,using a random number table method.Among them,three cases were excluded and one case was lost to follow-up in the control group,and ultimately 48 cases were included;two cases were excluded from the trial group,one case voluntarily withdrew,and ultimately 49 patients were included.The control group received oral Celecoxib Capsules,while the trial group received Yang's point penetration therapy on the basis of the control group.After four weeks of treatment,the clinical efficacy,pain status[Visual Analogue Scale(VAS)scores,and daily headache duration],cervical functional scores,traditional Chinese medicine(TCM)syndrome scores,sleep quality[Pittsburgh Sleep Quality Index(PSQI)],quality of life[Short-From 36 Health Surve(SF-36)],and safety were observed in the two groups.Results:The total effective rate was 93.88%(46/49)in the trial group,and 79.17%(38/48)in the control group,the difference being significant(P<0.05).After treatment,the VAS scores of pain and daily headahe duration in both groups were decreased when compared with those before treatment(P<0.05),and the VAS score of pain and daily headache duration in the trial group were lower than those in the control group(P<0.05).After treatment,the cervical spine functional scores,TCM syndrome scores and PSQI scores in both groups were decreased when compared with those before treatment(P<0.05),and the scores of three items in the trial group were lower than those in the control group(P<0.05).After treatment,the SF-36 scores in both groups were increased when compared with those before treatment(P<0.05),and the SF-36 score in the trial group was higher than that in the co

关 键 词：颈源性头痛 气滞血瘀 杨氏透穴疗法 塞来昔布胶囊 颈椎活动度 

分 类 号：R741[医药卫生—神经病学与精神病学]